alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.
Identifieur interne : 000B19 ( Hal/Curation ); précédent : 000B18; suivant : 000B20alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.
Auteurs : Anita Sidhu [États-Unis] ; Christophe Wersinger [États-Unis] ; Philippe Vernier [France]Source :
- FEBS Letters [ 1873-3468 ] ; 2004-05-07.
English descriptors
- mix :
Abstract
Parkinson's disease (PD) is a slow progressive neurodegenerative disorder. Recent evidence suggests a central role for alpha-synuclein, a protein of unknown function, in the genesis of PD. The phenomenon of selective degeneration of dopaminergic neurons in PD may be linked to the potential toxicity of dopamine itself and aberrations in the processes which regulate dopamine content may underlie the pathogenesis of this disease. Here, we review a vital role of alpha-synuclein in the modulation of dopamine transporter (DAT) function, and describe how disruption of this modulatory process permits increased re-uptake of high levels of intracellular dopamine by DAT, causing profound neurotoxicity.
Url:
DOI: 10.1016/j.febslet.2004.03.063
Links toward previous steps (curation, corpus...)
- to stream Hal, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000C22
Links to Exploration step
Hal:hal-00121743Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.</title><author><name sortKey="Sidhu, Anita" sort="Sidhu, Anita" uniqKey="Sidhu A" first="Anita" last="Sidhu">Anita Sidhu</name><affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-26275" status="INCOMING"><orgName>Laboratory of Molecular Neurochemistry, Department of Pediatrics</orgName><desc><address><addrLine>The Research Building, Room W222 3970 Reservoir Road, NW Washington, DC</addrLine><country key="US"></country></address></desc><listRelation><relation active="#struct-308313" type="direct"></relation></listRelation><tutelles><tutelle active="#struct-308313" type="direct"><org type="institution" xml:id="struct-308313" status="INCOMING"><orgName>Georgetown University</orgName><desc><address><country key="FR"></country></address></desc></org></tutelle></tutelles></hal:affiliation><country>États-Unis</country></affiliation></author><author><name sortKey="Wersinger, Christophe" sort="Wersinger, Christophe" uniqKey="Wersinger C" first="Christophe" last="Wersinger">Christophe Wersinger</name><affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-26275" status="INCOMING"><orgName>Laboratory of Molecular Neurochemistry, Department of Pediatrics</orgName><desc><address><addrLine>The Research Building, Room W222 3970 Reservoir Road, NW Washington, DC</addrLine><country key="US"></country></address></desc><listRelation><relation active="#struct-308313" type="direct"></relation></listRelation><tutelles><tutelle active="#struct-308313" type="direct"><org type="institution" xml:id="struct-308313" status="INCOMING"><orgName>Georgetown University</orgName><desc><address><country key="FR"></country></address></desc></org></tutelle></tutelles></hal:affiliation><country>États-Unis</country></affiliation></author><author><name sortKey="Vernier, Philippe" sort="Vernier, Philippe" uniqKey="Vernier P" first="Philippe" last="Vernier">Philippe Vernier</name><affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-1958" status="OLD"><orgName>Institut de Neurobiologie Alfred Fessard</orgName><orgName type="acronym">INAF</orgName><desc><address><addrLine>Bât. 32/33 1 Avenue de la terrasse 91198 GIF SUR YVETTE CEDEX</addrLine><country key="FR"></country></address><ref type="url">http://www.inaf.cnrs-gif.fr/</ref></desc><listRelation><relation name="FRC2118" active="#struct-441569" type="direct"></relation></listRelation><tutelles><tutelle name="FRC2118" active="#struct-441569" type="direct"><org type="institution" xml:id="struct-441569" status="VALID"><idno type="IdRef">02636817X</idno><idno type="ISNI">0000000122597504</idno><orgName>Centre National de la Recherche Scientifique</orgName><orgName type="acronym">CNRS</orgName><date type="start">1939-10-19</date><desc><address><country key="FR"></country></address><ref type="url">http://www.cnrs.fr/</ref></desc></org></tutelle></tutelles></hal:affiliation><country>France</country></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">HAL</idno><idno type="RBID">Hal:hal-00121743</idno><idno type="halId">hal-00121743</idno><idno type="halUri">https://hal.archives-ouvertes.fr/hal-00121743</idno><idno type="url">https://hal.archives-ouvertes.fr/hal-00121743</idno><idno type="doi">10.1016/j.febslet.2004.03.063</idno><date when="2004-05-07">2004-05-07</date><idno type="wicri:Area/Hal/Corpus">000C22</idno><idno type="wicri:Area/Hal/Curation">000C22</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.</title><author><name sortKey="Sidhu, Anita" sort="Sidhu, Anita" uniqKey="Sidhu A" first="Anita" last="Sidhu">Anita Sidhu</name><affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-26275" status="INCOMING"><orgName>Laboratory of Molecular Neurochemistry, Department of Pediatrics</orgName><desc><address><addrLine>The Research Building, Room W222 3970 Reservoir Road, NW Washington, DC</addrLine><country key="US"></country></address></desc><listRelation><relation active="#struct-308313" type="direct"></relation></listRelation><tutelles><tutelle active="#struct-308313" type="direct"><org type="institution" xml:id="struct-308313" status="INCOMING"><orgName>Georgetown University</orgName><desc><address><country key="FR"></country></address></desc></org></tutelle></tutelles></hal:affiliation><country>États-Unis</country></affiliation></author><author><name sortKey="Wersinger, Christophe" sort="Wersinger, Christophe" uniqKey="Wersinger C" first="Christophe" last="Wersinger">Christophe Wersinger</name><affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-26275" status="INCOMING"><orgName>Laboratory of Molecular Neurochemistry, Department of Pediatrics</orgName><desc><address><addrLine>The Research Building, Room W222 3970 Reservoir Road, NW Washington, DC</addrLine><country key="US"></country></address></desc><listRelation><relation active="#struct-308313" type="direct"></relation></listRelation><tutelles><tutelle active="#struct-308313" type="direct"><org type="institution" xml:id="struct-308313" status="INCOMING"><orgName>Georgetown University</orgName><desc><address><country key="FR"></country></address></desc></org></tutelle></tutelles></hal:affiliation><country>États-Unis</country></affiliation></author><author><name sortKey="Vernier, Philippe" sort="Vernier, Philippe" uniqKey="Vernier P" first="Philippe" last="Vernier">Philippe Vernier</name><affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-1958" status="OLD"><orgName>Institut de Neurobiologie Alfred Fessard</orgName><orgName type="acronym">INAF</orgName><desc><address><addrLine>Bât. 32/33 1 Avenue de la terrasse 91198 GIF SUR YVETTE CEDEX</addrLine><country key="FR"></country></address><ref type="url">http://www.inaf.cnrs-gif.fr/</ref></desc><listRelation><relation name="FRC2118" active="#struct-441569" type="direct"></relation></listRelation><tutelles><tutelle name="FRC2118" active="#struct-441569" type="direct"><org type="institution" xml:id="struct-441569" status="VALID"><idno type="IdRef">02636817X</idno><idno type="ISNI">0000000122597504</idno><orgName>Centre National de la Recherche Scientifique</orgName><orgName type="acronym">CNRS</orgName><date type="start">1939-10-19</date><desc><address><country key="FR"></country></address><ref type="url">http://www.cnrs.fr/</ref></desc></org></tutelle></tutelles></hal:affiliation><country>France</country></affiliation></author></analytic><idno type="DOI">10.1016/j.febslet.2004.03.063</idno><series><title level="j">FEBS Letters</title><idno type="ISSN">1873-3468</idno><imprint><date type="datePub">2004-05-07</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="mix" xml:lang="en"><term>1-Methyl-4-phenyl-1</term><term>6-tetrahydropyrimidine</term><term>Dopamine transporter</term><term>Lewy bodies</term><term>Parkinson's disease</term><term>Synucleinopathies</term><term>neurodegeneration</term><term>α-Synuclein</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Parkinson's disease (PD) is a slow progressive neurodegenerative disorder. Recent evidence suggests a central role for alpha-synuclein, a protein of unknown function, in the genesis of PD. The phenomenon of selective degeneration of dopaminergic neurons in PD may be linked to the potential toxicity of dopamine itself and aberrations in the processes which regulate dopamine content may underlie the pathogenesis of this disease. Here, we review a vital role of alpha-synuclein in the modulation of dopamine transporter (DAT) function, and describe how disruption of this modulatory process permits increased re-uptake of high levels of intracellular dopamine by DAT, causing profound neurotoxicity.</div></front></TEI><hal api="V3"><titleStmt><title xml:lang="en">alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.</title><author role="crp"><persName><forename type="first">Anita</forename><surname>Sidhu</surname></persName><email type="md5">44315ffac3a9ef0719513a8a21db2647</email><email type="domain">georgetown.edu</email><idno type="halauthorid">154080</idno><affiliation ref="#struct-26275"></affiliation><affiliation ref="#struct-1958"></affiliation></author><author role="aut"><persName><forename type="first">Christophe</forename><surname>Wersinger</surname></persName><idno type="halauthorid">80925</idno><affiliation ref="#struct-26275"></affiliation></author><author role="aut"><persName><forename type="first">Philippe</forename><surname>Vernier</surname></persName><idno type="halauthorid">80865</idno><affiliation ref="#struct-1958"></affiliation><affiliation ref="#struct-436"></affiliation></author><editor role="depositor"><persName><forename>Alain</forename><surname>PERIGNON</surname></persName><email type="md5">0915a8bc0b5a494fc86eb9724296445c</email><email type="domain">cnrs.fr</email></editor></titleStmt><editionStmt><edition n="v1" type="current"><date type="whenSubmitted">2006-12-21 17:24:08</date><date type="whenModified">2007-01-26 14:01:48</date><date type="whenReleased">2006-12-21 17:24:08</date><date type="whenProduced">2004-05-07</date></edition><respStmt><resp>contributor</resp><name key="108746"><persName><forename>Alain</forename><surname>PERIGNON</surname></persName><email type="md5">0915a8bc0b5a494fc86eb9724296445c</email><email type="domain">cnrs.fr</email></name></respStmt></editionStmt><publicationStmt><distributor>CCSD</distributor><idno type="halId">hal-00121743</idno><idno type="halUri">https://hal.archives-ouvertes.fr/hal-00121743</idno><idno type="halBibtex">sidhu:hal-00121743</idno><idno type="halRefHtml">FEBS Letters, Wiley, 2004, 565 (1-3), pp.1-5. <10.1016/j.febslet.2004.03.063></idno><idno type="halRef">FEBS Letters, Wiley, 2004, 565 (1-3), pp.1-5. <10.1016/j.febslet.2004.03.063></idno></publicationStmt><seriesStmt><idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno></seriesStmt><notesStmt><note type="audience" n="1">Not set</note><note type="popular" n="0">No</note><note type="peer" n="1">Yes</note></notesStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.</title><author role="crp"><persName><forename type="first">Anita</forename><surname>Sidhu</surname></persName><email type="md5">44315ffac3a9ef0719513a8a21db2647</email><email type="domain">georgetown.edu</email><idno type="halauthorid">154080</idno><affiliation ref="#struct-26275"></affiliation><affiliation ref="#struct-1958"></affiliation></author><author role="aut"><persName><forename type="first">Christophe</forename><surname>Wersinger</surname></persName><idno type="halauthorid">80925</idno><affiliation ref="#struct-26275"></affiliation></author><author role="aut"><persName><forename type="first">Philippe</forename><surname>Vernier</surname></persName><idno type="halauthorid">80865</idno><affiliation ref="#struct-1958"></affiliation><affiliation ref="#struct-436"></affiliation></author></analytic><monogr><idno type="halJournalId" status="VALID">13319</idno><idno type="issn">1873-3468</idno><title level="j">FEBS Letters</title><imprint><publisher>Wiley</publisher><biblScope unit="volume">565</biblScope><biblScope unit="issue">1-3</biblScope><biblScope unit="pp">1-5</biblScope><date type="datePub">2004-05-07</date></imprint></monogr><idno type="doi">10.1016/j.febslet.2004.03.063</idno><idno type="pubmed">15135042</idno></biblStruct></sourceDesc><profileDesc><langUsage><language ident="en">English</language></langUsage><textClass><keywords scheme="author"><term xml:lang="en">Dopamine transporter</term><term xml:lang="en">α-Synuclein</term><term xml:lang="en">Parkinson's disease</term><term xml:lang="en">Synucleinopathies</term><term xml:lang="en">1-Methyl-4-phenyl-1</term><term xml:lang="en">6-tetrahydropyrimidine</term><term xml:lang="en">neurodegeneration</term><term xml:lang="en">Lewy bodies</term></keywords><classCode scheme="mesh">Animals</classCode><classCode scheme="mesh">Dopamine Plasma Membrane Transport Proteins</classCode><classCode scheme="mesh">Synucleins</classCode><classCode scheme="mesh">alpha-Synuclein</classCode><classCode scheme="mesh">Humans</classCode><classCode scheme="mesh">Membrane Glycoproteins</classCode><classCode scheme="mesh">Membrane Transport Proteins</classCode><classCode scheme="mesh">Models, Biological</classCode><classCode scheme="mesh">Mutation</classCode><classCode scheme="mesh">Nerve Tissue Proteins</classCode><classCode scheme="mesh">Neurons</classCode><classCode scheme="mesh">Parkinson Disease</classCode><classCode scheme="halDomain" n="sdv.neu">Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]</classCode><classCode scheme="halTypology" n="ART">Journal articles</classCode></textClass><abstract xml:lang="en">Parkinson's disease (PD) is a slow progressive neurodegenerative disorder. Recent evidence suggests a central role for alpha-synuclein, a protein of unknown function, in the genesis of PD. The phenomenon of selective degeneration of dopaminergic neurons in PD may be linked to the potential toxicity of dopamine itself and aberrations in the processes which regulate dopamine content may underlie the pathogenesis of this disease. Here, we review a vital role of alpha-synuclein in the modulation of dopamine transporter (DAT) function, and describe how disruption of this modulatory process permits increased re-uptake of high levels of intracellular dopamine by DAT, causing profound neurotoxicity.</abstract></profileDesc></hal></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Hal/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B19 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Hal/Curation/biblio.hfd -nk 000B19 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Hal
|étape= Curation
|type= RBID
|clé= Hal:hal-00121743
|texte= alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.
}}
| This area was generated with Dilib version V0.6.29. |  |